<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TRIPELENNAMINE HYDROCHLORIDE</span><br/>(tri-pel-enn'a-meen)<br/><span class="topboxtradename">PBZ-SR, </span><span class="topboxtradename">Pelamine, </span><span class="topboxtradename">Pyribenzamine <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">antihistamine (h<sub>1</sub>-receptor antagonist)</span><br/><b>Prototype: </b>Diphenhydramine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>25 mg, 50 mg tablets; 100 mg sustained-release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Antihistamine with mild CNS depressant effects and relatively high incidence of GI side effects. Antagonizes histamine action
         (i.e., increased capillary permeability, edema formation, itching, and constriction of respiratory, GI, and vascular smooth
         muscle). Does not inhibit gastric secretion.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has antihistamine, antitussive, anticholinergic, and local anesthetic action.</p>
<h1><a name="uses">Uses</a></h1>
<p>To relieve symptoms of various allergic conditions, to ameliorate reactions to blood or plasma, and in anaphylaxis as adjunct
         to epinephrine and other standard measures after acute symptoms have been controlled. Also to provide oral mucous membrane
         analgesia in young children with herpetic gingiva-stomatitis.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Narrow-angle glaucoma; symptomatic prostatic hypertrophy; bladder neck obstruction; GI obstruction or stenosis; lower respiratory
         tract symptoms, including asthma; within 14 d of MAO inhibitor therapy. Safety during pregnancy (category B), lactation, or
         in neonates and prematures is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of asthma; convulsive disorders; increased intraocular pressure; hyperthyroidism; cardiovascular disease; hypertension;
         diabetes mellitus.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Allergic Conditions</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2550 mg q46h or 100 mg sustained-release q812h (max: 600 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 5 mg/kg/d in 46 divided doses (max: 300 mg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with or immediately after meals or food or with a glass of milk or water to lessen GI adverse effects.</li>
<li>Do not use sustained-release formulation (100 mg) with children of any age.</li>
<li>Do not crush, break, or chew sustained-release tablets. These must be swallowed whole.</li>
<li>Store in tight, light-resistant containers.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Respiratory:</span> Thickened bronchial secretions, wheezing, sensation of chest tightness. <span class="typehead">Special Senses:</span> Blurred vision, diplopia. <span class="typehead">Urogenital:</span> Urinary hesitancy or retention; dysuria. <span class="typehead">CV:</span> Palpitation, tachycardia, mild hypotension or hypertension, <span class="speceff-life">cardiovascular collapse</span>. <span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> dizziness, tinnitus, vertigo, fatigue, headache; disturbed coordination, tingling, tremors, euphoria, nervousness, restlessness,
      insomnia, hallucinations, excitement. <span class="typehead">GI:</span> <span class="speceff-common">Epigastric distress, anorexia, nausea, vomiting, constipation</span> or diarrhea, <span class="speceff-common">dry mouth, nose, </span>and <span class="speceff-common">throat</span>. <span class="typehead">Hematologic:</span> Leukopenia, hemolytic anemia. <span class="typehead">Skin:</span> Skin rash, urticaria, photosensitivity. <span class="typehead">Body as a Whole:</span> <span class="speceff-life">Anaphylactic shock</span>, fever, ataxia, athetosis, convulsions, <span class="speceff-life">coma</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span> add to CNS depression; <span class="classification">mao inhibitors</span> may intensify anticholinergic effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 1530 min.  <span class="typehead">Peak:</span> 23 h. <span class="typehead">Duration:</span> 46 h (up to 8 h with sustained-release). <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver.  <span class="typehead">Elimination:</span>  Excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assist older adults during ambulation; dizziness, sedation, and hypotension are more likely to occur in this age group.</li>
<li>Lab tests: Obtain periodic blood cell counts during long-term therapy with antihistamines.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Void just before taking drug if urinary hesitancy is a problem.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known. Mild to moderate drowsiness, blurred
            vision, and dizziness occur in some patients.
         </li>
<li>Be aware that the effects of antihistamines may be augmented by concomitant use of alcohol or other CNS depressants.</li>
<li>Do not take OTC preparations without consulting physician.</li>
<li>Discontinue antihistamines within 4 d before skin testing procedure for allergy because drug may interfere with reactions
            and obscure test results.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>